You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GS-1101

Showing 1 - 25 of 381
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia Trial in Germany (Tirabrutinib, Idelalisib, Obinutuzumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Frankfurt, Brandenburg, Germany
  • +13 more
Dec 24, 2021

Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Extranodal Marginal Zone Lymphoma of

Active, not recruiting
  • Recurrent B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • Scottsdale, Arizona
  • +1 more
Aug 10, 2021

Chronic Lymphocytic Leukemia (CLL) Trial in Columbus, Salt Lake City (Idelalisib, BI 836826)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia (CLL)
  • Columbus, Ohio
  • +1 more
Nov 23, 2020

Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Follicular Lymphoma Trial in Aichi, Miyagi, Tokyo (Idelalisib)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • +5 more
  • Aichi, Japan
  • +2 more
Feb 24, 2021

Leukemia, Lymphocytic, Chronic, B-Cell, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Worldwide

Completed
Has Results
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • +2 more
  • Tafasitamab
  • +2 more
  • Jacksonville, Florida
  • +16 more
Dec 10, 2021

Previously Untreated Pancreatic Ductal Adenocarcinoma, Relapsed/Refractory Pancreatic Ductal Adenocarcinoma Trial in United

Terminated
Has Results
  • Previously Untreated Pancreatic Ductal Adenocarcinoma
  • Relapsed/Refractory Pancreatic Ductal Adenocarcinoma
  • Scottsdale, Arizona
  • +8 more
Mar 31, 2021

Myelofibrosis Trial in Stanford, Ann Arbor (Idelalisib, Ruxolitinib)

Terminated
Has Results
  • Myelofibrosis
  • Stanford, California
  • +1 more
Aug 31, 2020

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Diffuse Large B-cell Lymphoma Trial in United States (Entospletinib,

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • +3 more
  • La Jolla, California
  • +12 more
May 18, 2020

Indolent Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma Trial in United States (Idelalisib,

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +2 more
  • Huntsville, Alabama
  • +10 more
Feb 22, 2021

Follicular Lymphoma Trial in Worldwide (Idelalisib)

Active, not recruiting
  • Follicular Lymphoma
  • Woodville South, South Australia, Australia
  • +65 more
Aug 24, 2022

Chronic Lymphocytic Leukemia, Lymphoma, Non-Hodgkin Trial in United States (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Lymphoma, Non-Hodgkin
  • Huntsville, Alabama
  • +17 more
Aug 22, 2019

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib)

Terminated
Has Results
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +44 more
Aug 12, 2019

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 21, 2020

Chronic Lymphocytic Leukemia Trial in Worldwide (Idelalisib, Rituximab, Bendamustine)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +105 more
Mar 2, 2020

Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in Palo Alto, New York (Idelalisib)

Completed
Has Results
  • Indolent Non-Hodgkin's Lymphoma
  • +3 more
  • Palo Alto, California
  • +1 more
Oct 19, 2018

Hodgkin Lymphoma Trial in New York, Houston, Seattle (Idelalisib)

Completed
Has Results
  • Hodgkin Lymphoma
  • New York, New York
  • +2 more
Oct 19, 2018

Follicular Lymphoma, Small Lymphocytic Lymphoma Trial in United States (Idelalisib, Rituximab)

Terminated
Has Results
  • Follicular Lymphoma
  • Small Lymphocytic Lymphoma
  • Long Beach, California
  • +5 more
May 1, 2019

Glioblastoma Multiforme of Brain Trial in Duarte (CHM-1101 CAR-T cells)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • CHM-1101 CAR-T cells
  • Duarte, California
    City of Hope Medical Center
Dec 19, 2022

Advanced Refractory Solid Tumors Trial in Tainan, Taipei (T-1101 (Tosylate))

Completed
  • Advanced Refractory Solid Tumors
  • T-1101 (Tosylate)
  • Taichung City, Taiwan
  • +3 more
Nov 17, 2022

Granuloma Annulare Trial in New Haven (AC-1101)

Recruiting
  • Granuloma Annulare
  • New Haven, Connecticut
    Yale Center for Clinical Investigation
Nov 2, 2022

Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial (GS-0272, Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Systemic Lupus Erythematosus
  • (no location specified)
Sep 4, 2023

Alcohol Consumption Trial in Palo Alto (Control, Goal Support (GS), Coaching for Context-specific Peer Support (CCPS))

Enrolling by invitation
  • Alcohol Consumption
  • Control
  • +2 more
  • Palo Alto, California
    Stanford University
May 8, 2023

Chronic Hepatitis B Trial (GS-2829, GS-6779, Placebo for GS-2829)

Not yet recruiting
  • Chronic Hepatitis B
  • GS-2829
  • +3 more
  • (no location specified)
Mar 14, 2023

Genetic Predisposition Trial in Tübingen (Next-Generation Sequencing (NGS))

Not yet recruiting
  • Genetic Predisposition
  • Next-Generation Sequencing (NGS)
  • Tübingen, Germany
    University Hospital Tübingen
Sep 22, 2023

Gastroschisis Trial in Houston (fetoscopy)

Recruiting
  • Gastroschisis
  • fetoscopy
  • Houston, Texas
    Texas Children's Hospital
Jan 20, 2023